Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Biotech
Biotech
ESMO: Pfizer sees weight gain in cancer patients, plots ph. 3
Cancer patients with wasting syndrome gained weight after taking a Pfizer antibody, leading the firm to target a 2025 start for its pivotal program.
Nick Paul Taylor
Sep 14, 2024 8:45am
AstraZeneca posts data on in-house rivals to AbbVie, Pfizer ADCs
Sep 14, 2024 3:00am
Sponsored
Market Insights: What’s Driving the Shift Toward FSP Models in Clinical Development?
Aug 20, 2024 8:00am
Regeneron's Opdualag rival shows 57% response rate
Sep 14, 2024 3:00am
Sponsored
Patient Access and Affordability: PhRMA shares how we can put patients first
Feb 12, 2024 8:00am
ESMO: Cancer vaccine and Keytruda deliver in phase 2 trial
Sep 14, 2024 2:30am
